South Korea’s MFDS approves Eisai-Biogen’s LEQEMBI for Alzheimer’s

The South Korean Ministry of Food and Drug Safety (MFDS) has granted approval for Eisai and Biogen’s LEQEMBI (lecanemab) for …

Dimerix and Taiba enter DMX-200 commercialisation deal in Middle East

Dimerix has entered into an exclusive licensing agreement worth up to nearly A$120.5m ($79.8m) with Taiba to commercialise its drug …

Dr. Reddy’s and Novartis sign distribution agreement for anti-diabetes products

Dr. Reddy's Laboratories' Russian subsidiary has signed an agreement with Novartis Pharma to carry out the sale and distribution of …

Lilly doubles investment in Indiana site to enhance API manufacturing

Eli Lilly has announced a substantial increase in its manufacturing investment at its site in Lebanon, Indiana, US, committing an …

ASCO 2024: MediLink’s NSCLC and breast cancer ADC shows early safety success

MediLink Therapeutics has announced early data with a HER3 antibody drug conjugate (ADC) that the biotech is codeveloping with BioNTech, …